NM_194454.3:c.146_147delGA

Variant summary

Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong

The NM_194454.3(KRIT1):​c.146_147delGA​(p.Arg49LysfsTer14) variant causes a frameshift change. The variant allele was found at a frequency of 0.0000031 in 1,611,308 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.

Frequency

Genomes: 𝑓 0.0000066 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000027 ( 0 hom. )

Consequence

KRIT1
NM_194454.3 frameshift

Scores

Not classified

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:5

Conservation

PhyloP100: 6.85

Publications

0 publications found
Variant links:
Genes affected
KRIT1 (HGNC:1573): (KRIT1 ankyrin repeat containing) This gene encodes a protein containing four ankyrin repeats, a band 4.1/ezrin/radixin/moesin (FERM) domain, and multiple NPXY sequences. The encoded protein is localized in the nucleus and cytoplasm. It binds to integrin cytoplasmic domain-associated protein-1 alpha (ICAP1alpha), and plays a critical role in beta1-integrin-mediated cell proliferation. It associates with junction proteins and RAS-related protein 1A (Rap1A), which requires the encoded protein for maintaining the integrity of endothelial junctions. It is also a microtubule-associated protein and may play a role in microtubule targeting. Mutations in this gene result in cerebral cavernous malformations. Multiple alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Sep 2009]
KRIT1 Gene-Disease associations (from GenCC):
  • cerebral cavernous malformation 1
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Genomics England PanelApp, Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • famililal cerebral cavernous malformations
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Pathogenic. The variant received 18 ACMG points.

PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 7-92241107-TTC-T is Pathogenic according to our data. Variant chr7-92241107-TTC-T is described in ClinVar as Pathogenic/Likely_pathogenic. ClinVar VariationId is 374400.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KRIT1NM_194454.3 linkc.146_147delGA p.Arg49LysfsTer14 frameshift_variant Exon 5 of 19 ENST00000394505.7 NP_919436.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KRIT1ENST00000394505.7 linkc.146_147delGA p.Arg49LysfsTer14 frameshift_variant Exon 5 of 19 1 NM_194454.3 ENSP00000378013.2
ENSG00000289027ENST00000692281.1 linkc.146_147delGA p.Arg49LysfsTer14 frameshift_variant Exon 5 of 26 ENSP00000510568.1
ENSG00000285953ENST00000458493.6 linkc.146_147delGA p.Arg49LysfsTer14 frameshift_variant Exon 4 of 20 4 ENSP00000396352.2

Frequencies

GnomAD3 genomes
AF:
0.00000657
AC:
1
AN:
152240
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000147
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000797
AC:
2
AN:
250792
AF XY:
0.0000147
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.0000176
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000274
AC:
4
AN:
1459068
Hom.:
0
AF XY:
0.00000138
AC XY:
1
AN XY:
726108
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33416
American (AMR)
AF:
0.00
AC:
0
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26116
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39656
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86186
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53390
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5760
European-Non Finnish (NFE)
AF:
0.00000361
AC:
4
AN:
1109520
Other (OTH)
AF:
0.00
AC:
0
AN:
60322
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.463
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
AF:
0.00000657
AC:
1
AN:
152240
Hom.:
0
Cov.:
32
AF XY:
0.00
AC XY:
0
AN XY:
74382
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41468
American (AMR)
AF:
0.00
AC:
0
AN:
15274
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4836
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10620
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000147
AC:
1
AN:
68044
Other (OTH)
AF:
0.00
AC:
0
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.00000378

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Cerebral cavernous malformation Pathogenic:4
Aug 28, 2025
Clinical Genomics Laboratory, Washington University in St. Louis
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

A KRIT1 c.146_147del (p.Arg49Lysfs*14) variant was identified at a near heterozygous allelic fraction of 44.4%, a frequency which may be consistent with it being of germline origin. This variant causes a frameshift by deleting two nucleotides, leading to a premature termination codon, which is predicted to lead to nonsense-mediated decay. This variant has been reported in one individual affected with cerebral cavernous malformation (Posey et al., PMID: 27959697). Other frameshift variants at the same codon c.143dup (p.Arg49Glufs*15) (Cavé-Riant F et al., PMID: 12404106; Spiegler S et al., PMID: 24689081), that also result in premature termination codons, have been identified in individuals affected with cerebral cavernous malformations. While pathogenic variants in the KRIT1 gene are typically identified in individuals with cerebral cavernous malformation, they have also been identified in individuals with cutaneous vascular malformations only, namely, hyperkeratotic cutaneous capillary-venous malformation (HCCVM) (Matarneh B et al., PMID: 34964173) as well as in multiple asymptomatic individuals (Ricci C et al., PMID: 33651268). The KRIT1 c.146_147del (p.Arg49Lysfs*14) variant is only observed on 5/1,611,308 alleles in the general population (gnomAD v.4.1.0), indicating it is not a common variant. It has been reported in the ClinVar database as a germline pathogenic variant by two submitters and a likely pathogenic variant by two submitters (ClinVar ID: 374400). Based on available information and the ACMG/AMP guidelines for variant interpretation (Richards S et al., PMID: 25741868), the KRIT1 c.146_147del (p.Arg49Lysfs*14) variant is classified as pathogenic.

May 11, 2021
Revvity Omics, Revvity
Significance:Likely pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

May 20, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Pathogenic
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This sequence change creates a premature translational stop signal (p.Arg49Lysfs*14) in the KRIT1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in KRIT1 are known to be pathogenic (PMID: 10508515, 11222804, 12404106, 24689081). This variant is present in population databases (no rsID available, gnomAD 0.002%). This variant has not been reported in the literature in individuals affected with KRIT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 374400). For these reasons, this variant has been classified as Pathogenic.

May 01, 2016
Baylor Genetics
Significance:Likely pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

Our laboratory reported two molecular diagnoses in COL11A1 (NM_080630.2:c.2754+5G>A) and KRIT1 (NM_194456.1:c.146_147del) in an individual with hearing loss, tics, dysmorphic features, macrocephaly, vision loss, chronic otitis media, reactive airway disease, food allergy, urticaria, eczema, and keratosis pilaris.

KRIT1-related disorder Pathogenic:1
Jun 20, 2024
PreventionGenetics, part of Exact Sciences
Significance:Pathogenic
Review Status:no assertion criteria provided
Collection Method:clinical testing

The KRIT1 c.146_147delGA variant is predicted to result in a frameshift and premature protein termination (p.Arg49Lysfs*14). This variant has been reported to be causative for cerebral cavernous malformations (Posey et al. 2017. PubMed ID: 27959697). At PreventionGenetics, we have observed this variant in several, apparently unrelated, affected individuals. This variant is reported in 0.0018% of alleles in individuals of European (non-Finnish) descent in gnomAD. Frameshift variants in KRIT1 are expected to be pathogenic. This variant is interpreted as pathogenic.

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
6.9
Mutation Taster
=0/200
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1057518665; hg19: chr7-91870421; API